Cargando…
Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China
BACKGROUND: Renal replacement therapy was a lifesaving yet high-cost treatment for people with end-stage kidney disease (ESKD). This study aimed to estimate the direct medical costs per capita of ESKD by different treatment strategies: haemodialysis (HD); peritoneal dialysis (PD); kidney transplanta...
Autores principales: | Zhang, Hui, Zhang, Chao, Zhu, Sufen, Ye, Hongjian, Zhang, Donglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023821/ https://www.ncbi.nlm.nih.gov/pubmed/32059726 http://dx.doi.org/10.1186/s12913-020-4960-x |
Ejemplares similares
-
Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China
por: Zhang, Hui, et al.
Publicado: (2019) -
Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
por: Yang, Fei, et al.
Publicado: (2021) -
Direct medical costs for patients with schizophrenia: a 4-year cohort study from health insurance claims data in Guangzhou city, Southern China
por: Zhang, Hui, et al.
Publicado: (2018) -
Direct Medical Costs of Parkinson’s Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City
por: Zhang, Hui, et al.
Publicado: (2022) -
Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City
por: Xie, Peixuan, et al.
Publicado: (2023)